0001564590-20-018982.txt : 20200428 0001564590-20-018982.hdr.sgml : 20200428 20200428065356 ACCESSION NUMBER: 0001564590-20-018982 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20200428 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20200428 DATE AS OF CHANGE: 20200428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASHLAND GLOBAL HOLDINGS INC CENTRAL INDEX KEY: 0001674862 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-CHEMICALS & ALLIED PRODUCTS [5160] IRS NUMBER: 812587835 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-211719 FILM NUMBER: 20822216 BUSINESS ADDRESS: STREET 1: 8145 BLAZER DRIVE CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 304-995-3000 MAIL ADDRESS: STREET 1: 8145 BLAZER DRIVE CITY: WILMINGTON STATE: DE ZIP: 19808 8-K 1 ash-8k_20200428.htm 8-K ash-8k_20200428.htm
false 0001674862 0001674862 2020-04-28 2020-04-28

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  April 28, 2020

ASHLAND GLOBAL HOLDINGS INC.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation) 

 

333-211719

 

81-2587835

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

8145 Blazer Drive

Wilmington, DE 19808

Registrant’s telephone number, including area code (302) 995-3000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock (par value $.01)

 

ASH

 

NYSE

 

 

 

 

 


Item 7.01.  Regulation FD Disclosure.

 

During the second quarter of fiscal year 2020, Ashland Global Holdings Inc. (“Ashland”) changed the manner in which it manages the business, moving from a functionally-led to a business-led organization.  As a result, Ashland’s operations are now managed by the chief operating decision maker within the following five reportable segments:

 

 

Life Sciences: this segment is comprised of pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, advanced materials and fine chemicals.

 

 

Personal Care & Household: this segment is comprised of biofunctionals, preservatives, skin care, sun care, oral care, hair care and household.

 

 

Specialty Additives: this segment is comprised of rheology- and performance-enhancing additives serving the coatings, construction, energy, automotive and various industrial markets.

 

 

Performance Adhesives: this segment is comprised of adhesives used in packaging, converting and structural applications.

 

 

Intermediates & Solvents: this segment is comprised of the production of 1,4 butanediol (BDO) and related derivatives serving diverse end markets as well as providing feedstocks for the Life Sciences and Personal Care segments.  

 

 

Unallocated and Other generally includes items such as certain significant company-wide restructuring activities, corporate governance costs and legacy costs or adjustments that relate to divested businesses that are no longer operated by Ashland.

 

Ashland is providing summary historical financial information for the four quarters of fiscal year 2019 and the first quarter of fiscal year 2020 based upon the new segment reporting adopted during the second quarter of fiscal year 2020 within Tables 1 through 6.

 

These segment changes have no impact on our historical consolidated balance sheets, statements of earnings or cash flows. The recast unaudited information related to Ashland’s previously issued historical financial information that is provided in this Current Report on Form 8-K is revised on a basis that is consistent with the reorganization of Ashland’s reportable segments.  This Current Report on Form 8-K should be read in conjunction with Ashland’s Quarterly Reports on Form 10-Q for the four quarters of fiscal year 2019 and the first quarter of fiscal year 2020 filed with the Securities and Exchange Commission.

 

2

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

Table 1

 

ADJUSTED RESULTS SUMMARY (a)

 

 

 

 

 

 

 

 

 

(in millions except percentages - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

December 31, 2018

 

 

March 30,

2019

 

 

June 30,

2019

 

 

September 30, 2019

 

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life Sciences

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

170

 

 

$

196

 

 

$

190

 

 

$

176

 

 

$

155

 

Adjusted EBITDA

 

38

 

 

 

48

 

 

 

47

 

 

 

41

 

 

 

37

 

     Adjusted EBITDA Margin

 

22.4

%

 

 

24.5

%

 

 

24.7

%

 

 

23.3

%

 

 

23.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care & Household

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

154

 

 

$

183

 

 

$

158

 

 

$

157

 

 

$

137

 

Adjusted EBITDA

 

37

 

 

 

44

 

 

 

37

 

 

 

47

 

 

 

30

 

     Adjusted EBITDA Margin

 

24.0

%

 

 

24.0

%

 

 

23.4

%

 

 

29.9

%

 

 

21.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Specialties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

324

 

 

$

379

 

 

$

348

 

 

$

333

 

 

$

292

 

Adjusted EBITDA

 

75

 

 

 

92

 

 

 

84

 

 

 

88

 

 

 

67

 

     Adjusted EBITDA Margin

 

23.1

%

 

 

24.3

%

 

 

24.1

%

 

 

26.4

%

 

 

22.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Specialty Additives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

148

 

 

$

169

 

 

$

177

 

 

$

161

 

 

$

139

 

Adjusted EBITDA

 

26

 

 

 

38

 

 

 

42

 

 

 

44

 

 

 

29

 

     Adjusted EBITDA Margin

 

17.6

%

 

 

22.5

%

 

 

23.7

%

 

 

27.3

%

 

 

20.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Performance Adhesives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

81

 

 

$

89

 

 

$

88

 

 

$

85

 

 

$

74

 

Adjusted EBITDA

 

13

 

 

 

21

 

 

 

20

 

 

 

19

 

 

 

15

 

     Adjusted EBITDA Margin

 

16.0

%

 

 

23.6

%

 

 

22.7

%

 

 

22.4

%

 

 

20.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Industrial Specialties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

229

 

 

$

258

 

 

$

265

 

 

$

246

 

 

$

213

 

Adjusted EBITDA

 

39

 

 

 

59

 

 

 

62

 

 

 

63

 

 

 

44

 

     Adjusted EBITDA Margin

 

17.0

%

 

 

22.9

%

 

 

23.4

%

 

 

25.6

%

 

 

20.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intermediates & Solvents

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

33

 

 

$

44

 

 

$

41

 

 

$

42

 

 

$

28

 

Adjusted EBITDA

 

5

 

 

 

12

 

 

 

12

 

 

 

13

 

 

 

(9

)

     Adjusted EBITDA Margin

 

15.2

%

 

 

27.3

%

 

 

29.3

%

 

 

31.0

%

 

 

-32.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate & Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

(10

)

 

$

(14

)

 

$

(13

)

 

$

(12

)

 

$

-

 

Adjusted EBITDA

 

(19

)

 

 

(21

)

 

 

(18

)

 

 

(14

)

 

 

(14

)

     Adjusted EBITDA Margin

N/M

 

 

N/M

 

 

N/M

 

 

N/M

 

 

N/M

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ashland Global Holdings Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

$

576

 

 

$

667

 

 

$

641

 

 

$

609

 

 

$

533

 

Adjusted EBITDA

 

100

 

 

 

142

 

 

 

140

 

 

 

150

 

 

 

88

 

     Adjusted EBITDA Margin

 

17.4

%

 

 

21.3

%

 

 

21.8

%

 

 

24.6

%

 

 

16.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) All figures are presented on an adjusted basis except Sales.  Tables 2 through 6 reconcile adjusted amounts to amounts reported under GAAP, including reconciliations of Net Income to Adjusted EBITDA.  Adjusted EBITDA Margin is calculated as Adjusted EBITDA divided by Sales.

 

 

3


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 2

 

STATEMENTS OF CONSOLIDATED INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2018

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

Sales

$

170

 

 

$

154

 

 

$

324

 

 

$

148

 

 

$

81

 

 

$

229

 

 

$

33

 

 

$

(10

)

 

$

576

 

Cost of sales

 

 

 

 

 

 

 

 

 

208

 

 

 

 

 

 

 

 

 

 

 

198

 

 

 

28

 

 

 

(10

)

 

 

424

 

GROSS PROFIT

 

 

 

 

 

 

 

 

 

116

 

 

 

 

 

 

 

 

 

 

 

31

 

 

 

5

 

 

 

-

 

 

 

152

 

Selling, general and administrative expense

 

 

 

 

 

 

 

 

 

48

 

 

 

 

 

 

 

 

 

 

 

34

 

 

 

3

 

 

 

37

 

 

 

122

 

Research and development expense

 

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

-

 

 

 

-

 

 

 

17

 

Intangible amortization expense

 

 

 

 

 

 

 

 

 

16

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

-

 

 

 

-

 

 

 

21

 

Equity and Other Income

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

1

 

 

 

1

 

OPERATING INCOME (LOSS)

 

23

 

 

 

18

 

 

 

41

 

 

 

(23

)

 

 

9

 

 

 

(14

)

 

 

2

 

 

 

(36

)

 

 

(7

)

Net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

55

 

 

 

55

 

Other net periodic benefit income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

18

 

Net income (loss) on divestitures

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

(3

)

 

 

(3

)

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

23

 

 

 

18

 

 

 

41

 

 

 

(23

)

 

 

9

 

 

 

(14

)

 

 

2

 

 

 

(76

)

 

 

(47

)

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24

 

 

 

24

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

23

 

 

 

18

 

 

 

41

 

 

 

(23

)

 

 

9

 

 

 

(14

)

 

 

2

 

 

 

(100

)

 

 

(71

)

Income (loss) from discontinued operations (net of income taxes)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

23

 

 

 

23

 

NET INCOME (LOSS)

$

23

 

 

$

18

 

 

$

41

 

 

$

(23

)

 

$

9

 

 

$

(14

)

 

$

2

 

 

$

(77

)

 

$

(48

)

 

 

4

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

 

 

 

 

Table 2 - Continued

 

SEGMENT COMPONENTS OF KEY ITEMS FOR APPLICABLE INCOME STATEMENT CAPTIONS

 

 

 

 

 

 

 

 

 

(In millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2018

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

OPERATING INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating key items

$

-

 

 

$

-

 

 

$

-

 

 

$

(28

)

 

$

-

 

 

$

(28

)

 

$

-

 

 

$

(17

)

 

$

(45

)

All other operating income (loss)

 

23

 

 

 

18

 

 

 

41

 

 

 

5

 

 

 

9

 

 

 

14

 

 

 

2

 

 

 

(19

)

 

 

38

 

Operating income (loss)

 

23

 

 

 

18

 

 

 

41

 

 

 

(23

)

 

 

9

 

 

 

(14

)

 

 

2

 

 

 

(36

)

 

 

(7

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INTEREST AND OTHER EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

30

 

 

 

30

 

All other net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

25

 

 

 

25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS) ON DIVESTITURES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3

)

 

 

(3

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX EXPENSE (BENEFIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8

)

 

 

(8

)

Tax specific key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

2

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22

 

 

 

22

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

3

 

All other income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER NET PERIODIC BENEFIT INCOME (COSTS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 

 

 

18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

$

23

 

 

$

18

 

 

$

41

 

 

$

(23

)

 

$

9

 

 

$

(14

)

 

$

2

 

 

$

(100

)

 

$

(71

)

 

5

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 2 - Continued

 

RECONCILIATION OF NON-GAAP DATA - ADJUSTED EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2018

 

 

Life Sciences

 

 

Personal Care & Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) (as reported)

$

23

 

 

$

18

 

 

$

41

 

 

$

(23

)

 

$

9

 

 

$

(14

)

 

$

2

 

 

$

(77

)

 

$

(48

)

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

24

 

 

 

24

 

Net interest and other expense

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

55

 

 

 

55

 

Subtotal

 

23

 

 

 

18

 

 

 

41

 

 

 

(23

)

 

 

9

 

 

 

(14

)

 

 

2

 

 

 

2

 

 

 

31

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Depreciation and amortization (a)

 

15

 

 

 

19

 

 

 

34

 

 

 

21

 

 

 

4

 

 

 

25

 

 

 

3

 

 

 

-

 

 

 

62

 

     Operating key items

 

-

 

 

 

-

 

 

 

-

 

 

 

28

 

 

 

-

 

 

 

28

 

 

 

-

 

 

 

17

 

 

 

45

 

     Net income (loss) on divestitures key items

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

3

 

 

 

3

 

     Income (loss) from discontinued operations

     (net of taxes)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(23

)

 

 

(23

)

     Gain on pension and other postretirement

     plan remeasurements

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(18

)

 

 

(18

)

Adjusted EBITDA (non-GAAP)

$

38

 

 

$

37

 

 

$

75

 

 

$

26

 

 

$

13

 

 

$

39

 

 

$

5

 

 

$

(19

)

 

$

100

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Depreciation and amortization excludes accelerated depreciation of $19 million for Specialty Additives for the three months ended December 31, 2018 which is included as a key item within this table.

 

 

6

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 2 - Continued

 

RECONCILIATION OF CERTAIN NON-GAAP DATA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2018

 

 

Life Sciences

 

 

Personal Care & Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS from continuing operations (as reported)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(1.14

)

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Restructuring, separation and other costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.71

 

     Gain on pension and other postretirement

     plan measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.29

)

     Unrealized (gain) loss on securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.47

 

     Net loss on acquisitions and divestitures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.05

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.94

 

Tax effect of key items (a)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.11

)

Key items, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.83

 

Tax specific key items (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.03

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.35

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.02

 

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.05

 

Tax specific key items:

 

 

 

 

 

 

 

 

 

 

 

0.45

 

Total key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1.28

 

Adjusted diluted EPS from continuing operations (non-GAAP)

 

 

 

 

 

 

 

 

 

 

$

0.14

 

Amortization expense, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.26

 

Adjusted diluted EPS from continuing operations excluding intangible amortization expense (non-GAAP)

 

 

 

 

 

 

 

 

 

 

$

0.40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Diluted Common Shares Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

63

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Represents the tax effect of the key items that are previously identified above.

 

(b) Represents key items resulting from tax specific financial transactions, tax law changes or other matters that fall within the definition of tax specific key items.

 

 

 

 

7

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 3

 

STATEMENTS OF CONSOLIDATED INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

Sales

$

196

 

 

$

183

 

 

$

379

 

 

$

169

 

 

$

89

 

 

$

258

 

 

$

44

 

 

$

(14

)

 

$

667

 

Cost of sales

 

 

 

 

 

 

 

 

 

249

 

 

 

 

 

 

 

 

 

 

 

201

 

 

 

33

 

 

 

(14

)

 

 

469

 

GROSS PROFIT

 

 

 

 

 

 

 

 

 

130

 

 

 

 

 

 

 

 

 

 

 

57

 

 

 

11

 

 

 

-

 

 

 

198

 

Selling, general and administrative expense

 

 

 

 

 

 

 

 

 

45

 

 

 

 

 

 

 

 

 

 

 

31

 

 

 

2

 

 

 

37

 

 

 

115

 

Research and development expense

 

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

-

 

 

 

-

 

 

 

17

 

Intangible amortization expense

 

 

 

 

 

 

 

 

 

16

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

-

 

 

 

-

 

 

 

21

 

Equity and Other Income

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

(1

)

 

 

(1

)

OPERATING INCOME (LOSS)

 

33

 

 

 

25

 

 

 

58

 

 

 

(2

)

 

 

17

 

 

 

15

 

 

 

9

 

 

 

(38

)

 

 

44

 

Net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3

)

 

 

(3

)

Other net periodic benefit income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1

)

 

 

(1

)

Net income (loss) on divestitures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

33

 

 

 

25

 

 

 

58

 

 

 

(2

)

 

 

17

 

 

 

15

 

 

 

9

 

 

 

(36

)

 

 

46

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

33

 

 

 

25

 

 

 

58

 

 

 

(2

)

 

 

17

 

 

 

15

 

 

 

9

 

 

 

(37

)

 

 

45

 

Income (loss) from discontinued operations (net of income taxes)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31

 

 

 

31

 

NET INCOME (LOSS)

$

33

 

 

$

25

 

 

$

58

 

 

$

(2

)

 

$

17

 

 

$

15

 

 

$

9

 

 

$

(6

)

 

$

76

 

 

 

8

 


 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 3 - Continued

 

SEGMENT COMPONENTS OF KEY ITEMS FOR APPLICABLE INCOME STATEMENT CAPTIONS

 

 

 

 

 

 

 

 

 

(In millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating key items

$

-

 

 

$

-

 

 

$

-

 

 

$

(20

)

 

$

-

 

 

$

(20

)

 

$

-

 

 

$

(17

)

 

$

(37

)

All other operating income (loss)

 

33

 

 

 

25

 

 

 

58

 

 

 

18

 

 

 

17

 

 

 

35

 

 

 

9

 

 

 

(21

)

 

 

81

 

Operating income (loss)

 

33

 

 

 

25

 

 

 

58

 

 

 

(2

)

 

 

17

 

 

 

15

 

 

 

9

 

 

 

(38

)

 

 

44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INTEREST AND OTHER EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(27

)

 

 

(27

)

All other net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24

 

 

 

24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS) ON DIVESTITURES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX EXPENSE (BENEFIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

2

 

Tax specific key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2

)

 

 

(2

)

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3

)

 

 

(3

)

All other income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER NET PERIODIC BENEFIT INCOME (COSTS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1

)

 

 

(1

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

$

33

 

 

$

25

 

 

$

58

 

 

$

(2

)

 

$

17

 

 

$

15

 

 

$

9

 

 

$

(37

)

 

$

45

 

 

9

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 3 - Continued

 

RECONCILIATION OF NON-GAAP DATA - ADJUSTED EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) (as reported)

$

33

 

 

$

25

 

 

$

58

 

 

$

(2

)

 

$

17

 

 

$

15

 

 

$

9

 

 

$

(6

)

 

$

76

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

1

 

 

 

1

 

Net interest and other expense

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(3

)

 

 

(3

)

Subtotal

 

33

 

 

 

25

 

 

 

58

 

 

 

(2

)

 

 

17

 

 

 

15

 

 

 

9

 

 

 

(8

)

 

 

74

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Depreciation and amortization (a)

 

15

 

 

 

19

 

 

 

34

 

 

 

20

 

 

 

4

 

 

 

24

 

 

 

3

 

 

 

1

 

 

 

62

 

     Operating key items

 

-

 

 

 

-

 

 

 

-

 

 

 

20

 

 

 

-

 

 

 

20

 

 

 

-

 

 

 

17

 

 

 

37

 

     Net income (loss) on divestitures key items

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

     Income (loss) from discontinued operations

     (net of taxes)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(31

)

 

 

(31

)

     Gain on pension and other postretirement

    plan remeasurements

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

Adjusted EBITDA (non-GAAP)

$

48

 

 

$

44

 

 

$

92

 

 

$

38

 

 

$

21

 

 

$

59

 

 

$

12

 

 

$

(21

)

 

$

142

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Depreciation and amortization exclude accelerated depreciation of $19 million for Specialty Additives for the three months ended March 31, 2019 and $1 million for Unallocated and Other for the three months ended March 31, 2019, which are included as a key item within this table.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 3 - Continued

 

RECONCILIATION OF CERTAIN NON-GAAP DATA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended March 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS from continuing operations (as reported)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.71

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Restructuring, separation and other costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.58

 

     Gain on pension and other postretirement

     plan measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     Unrealized (gain) loss on securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.42

)

     Net loss on acquisitions and divestitures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.16

 

Tax effect of key items (a)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.04

 

Key items, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.20

 

Tax specific key items (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.03

)

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.05

)

Tax specific key items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.08

)

Total key items

 

 

 

 

 

 

 

 

 

 

 

0.12

 

Adjusted diluted EPS from continuing

operations (non-GAAP)

 

 

 

 

 

 

 

 

 

 

$

0.83

 

Amortization expense, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.25

 

Adjusted diluted EPS from continuing operations excluding intangible amortization expense (non-GAAP)

 

 

 

 

 

 

 

 

 

 

$

1.08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Diluted Common Shares Outstanding

 

 

 

 

 

 

 

 

 

 

 

64

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Represents the tax effect of the key items that are previously identified above.

 

(b) Represents key items resulting from tax specific financial transactions, tax law changes or other matters that fall within the definition of tax specific key items.

 

 

 

 

11

 


 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 4

 

STATEMENTS OF CONSOLIDATED INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

Sales

$

190

 

 

$

158

 

 

$

348

 

 

$

177

 

 

$

88

 

 

$

265

 

 

$

41

 

 

$

(13

)

 

$

641

 

Cost of sales

 

 

 

 

 

 

 

 

 

227

 

 

 

 

 

 

 

 

 

 

 

190

 

 

 

30

 

 

 

(13

)

 

 

434

 

GROSS PROFIT

 

 

 

 

 

 

 

 

 

121

 

 

 

 

 

 

 

 

 

 

 

75

 

 

 

11

 

 

 

-

 

 

 

207

 

Selling, general and administrative expense

 

 

 

 

 

 

 

 

 

45

 

 

 

 

 

 

 

 

 

 

 

29

 

 

 

2

 

 

 

53

 

 

 

129

 

Research and development expense

 

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

-

 

 

 

-

 

 

 

17

 

Intangible amortization expense

 

 

 

 

 

 

 

 

 

16

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

-

 

 

 

-

 

 

 

21

 

Equity and Other Income

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

3

 

 

 

3

 

OPERATING INCOME (LOSS)

 

32

 

 

 

17

 

 

 

49

 

 

 

19

 

 

 

16

 

 

 

35

 

 

 

9

 

 

 

(50

)

 

 

43

 

Net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

21

 

 

 

21

 

Other net periodic benefit income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

Net income (loss) on divestitures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

32

 

 

 

17

 

 

 

49

 

 

 

19

 

 

 

16

 

 

 

35

 

 

 

9

 

 

 

(71

)

 

 

22

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1

)

 

 

(1

)

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

32

 

 

 

17

 

 

 

49

 

 

 

19

 

 

 

16

 

 

 

35

 

 

 

9

 

 

 

(70

)

 

 

23

 

Income (loss) from discontinued operations (net of income taxes)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

43

 

 

 

43

 

NET INCOME (LOSS)

$

32

 

 

$

17

 

 

$

49

 

 

$

19

 

 

$

16

 

 

$

35

 

 

$

9

 

 

$

(27

)

 

$

66

 

 

 

12

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 4 - Continued

 

SEGMENT COMPONENTS OF KEY ITEMS FOR APPLICABLE INCOME STATEMENT CAPTIONS

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating key items

$

-

 

 

$

-

 

 

$

-

 

 

$

(3

)

 

$

-

 

 

$

(3

)

 

$

-

 

 

$

(32

)

 

$

(35

)

All other operating income (loss)

 

32

 

 

 

17

 

 

 

49

 

 

 

22

 

 

 

16

 

 

 

38

 

 

 

9

 

 

 

(18

)

 

 

78

 

Operating income (loss)

 

32

 

 

 

17

 

 

 

49

 

 

 

19

 

 

 

16

 

 

 

35

 

 

 

9

 

 

 

(50

)

 

 

43

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INTEREST AND OTHER EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(6

)

 

 

(6

)

All other net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

27

 

 

 

27

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS) ON DIVESTITURES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX EXPENSE (BENEFIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5

)

 

 

(5

)

Tax specific key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

6

 

     Uncertain tax positions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(8

)

 

 

(8

)

     Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

3

 

All other income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER NET PERIODIC BENEFIT INCOME (COSTS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

$

32

 

 

$

17

 

 

$

49

 

 

$

19

 

 

$

16

 

 

$

35

 

 

$

9

 

 

$

(70

)

 

$

23

 

 

13

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 4 - Continued

 

RECONCILIATION OF NON-GAAP-DATA - ADJUSTED EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) (as Reported)

$

32

 

 

$

17

 

 

$

49

 

 

$

19

 

 

$

16

 

 

$

35

 

 

$

9

 

 

$

(27

)

 

$

66

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(1

)

 

 

(1

)

Net interest and other expense

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

21

 

 

 

21

 

Subtotal

 

32

 

 

 

17

 

 

 

49

 

 

 

19

 

 

 

16

 

 

 

35

 

 

 

9

 

 

 

(7

)

 

 

86

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Depreciation and amortization

 

15

 

 

 

20

 

 

 

35

 

 

 

20

 

 

 

4

 

 

 

24

 

 

 

3

 

 

 

-

 

 

 

62

 

     Operating key items

 

-

 

 

 

-

 

 

 

-

 

 

 

3

 

 

 

-

 

 

 

3

 

 

 

-

 

 

 

32

 

 

 

35

 

     Net income (loss) on divestitures key items

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

     Income (loss) from discontinued operations

     (net of taxes)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(43

)

 

 

(43

)

     Gain on pension and other postretirement

     plan remeasurements

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

Adjusted EBITDA (non-GAAP)

$

47

 

 

$

37

 

 

$

84

 

 

$

42

 

 

$

20

 

 

$

62

 

 

$

12

 

 

$

(18

)

 

$

140

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 4 - Continued

 

RECONCILIATION OF NON-GAAP-DATA - ADJUSTED EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS from continuing operations (as reported)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.37

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Restructuring, separation and other costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.19

 

     Tax indemnity expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.10

 

     Environmental reserve adjustment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.24

 

     Unplanned plant shutdowns

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.03

 

     Unrealized (gain) loss on securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.10

)

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.46

 

Tax effect of key items (a)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.08

)

Key items, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.38

 

Tax specific key items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.10

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.13

)

     Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.05

 

Tax specific key items (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.02

 

Total key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.40

 

Adjusted diluted EPS from continuing operations (non-GAAP)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.77

 

Amortization expense, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.25

 

Adjusted diluted EPS from continuing operations excluding intangible amortization expense (non-GAAP)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

1.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Diluted Common Shares Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

62

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Represents the tax effect of the key items that are previously identified above.

 

(b) Represents key items resulting from tax specific financial transactions, tax law changes or other matters that fall within the definition of tax specific key items.

 

 

 

 

15

 


 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 5

 

STATEMENTS OF CONSOLIDATED INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

Sales

$

176

 

 

$

157

 

 

$

333

 

 

$

161

 

 

$

85

 

 

$

246

 

 

$

42

 

 

$

(12

)

 

$

609

 

Cost of sales

 

 

 

 

 

 

 

 

 

212

 

 

 

 

 

 

 

 

 

 

 

170

 

 

 

30

 

 

 

(12

)

 

 

400

 

GROSS PROFIT

 

 

 

 

 

 

 

 

 

121

 

 

 

 

 

 

 

 

 

 

 

76

 

 

 

12

 

 

 

-

 

 

 

209

 

Selling, general and administrative expense

 

 

 

 

 

 

 

 

 

42

 

 

 

 

 

 

 

 

 

 

 

28

 

 

 

3

 

 

 

15

 

 

 

88

 

Research and development expense

 

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

-

 

 

 

-

 

 

 

15

 

Intangible amortization expense

 

 

 

 

 

 

 

 

 

16

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

-

 

 

 

-

 

 

 

21

 

Equity and Other Income

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

OPERATING INCOME (LOSS)

 

26

 

 

 

27

 

 

 

53

 

 

 

23

 

 

 

15

 

 

 

38

 

 

 

9

 

 

 

(15

)

 

 

85

 

Net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

26

 

 

 

26

 

Other net periodic benefit income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(11

)

 

 

(11

)

Net income (loss) on divestitures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

26

 

 

 

27

 

 

 

53

 

 

 

23

 

 

 

15

 

 

 

38

 

 

 

9

 

 

 

(51

)

 

 

49

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22

 

 

 

22

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

26

 

 

 

27

 

 

 

53

 

 

 

23

 

 

 

15

 

 

 

38

 

 

 

9

 

 

 

(73

)

 

 

27

 

Income (loss) from discontinued operations (net of income taxes)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

384

 

 

 

384

 

NET INCOME (LOSS)

$

26

 

 

$

27

 

 

$

53

 

 

$

23

 

 

$

15

 

 

$

38

 

 

$

9

 

 

$

311

 

 

$

411

 

 

 

16

 


 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 5 - Continued

 

SEGMENT COMPONENTS OF KEY ITEMS FOR APPLICABLE INCOME STATEMENT CAPTIONS

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating key items

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

All other operating income (loss)

 

26

 

 

 

27

 

 

 

53

 

 

 

23

 

 

 

15

 

 

 

38

 

 

 

9

 

 

 

(15

)

 

 

85

 

Operating income (loss)

 

26

 

 

 

27

 

 

 

53

 

 

 

23

 

 

 

15

 

 

 

38

 

 

 

9

 

 

 

(15

)

 

 

85

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INTEREST AND OTHER EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

All other net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

25

 

 

 

25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS) ON DIVESTITURES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX EXPENSE (BENEFIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3

)

 

 

(3

)

Tax specific key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Uncertain tax positions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

2

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

13

 

 

 

13

 

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4

)

 

 

(4

)

All other income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14

 

 

 

14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER NET PERIODIC BENEFIT INCOME (COSTS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(11

)

 

 

(11

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

$

26

 

 

$

27

 

 

$

53

 

 

$

23

 

 

$

15

 

 

$

38

 

 

$

9

 

 

$

(73

)

 

$

27

 

 

17

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 5 - Continued

 

RECONCILIATION OF NON-GAAP DATA - ADJUSTED EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) (as Reported)

$

26

 

 

$

27

 

 

$

53

 

 

$

23

 

 

$

15

 

 

$

38

 

 

$

9

 

 

$

311

 

 

$

411

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

22

 

 

 

22

 

Net interest and other expense

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

26

 

 

 

26

 

Subtotal

 

26

 

 

 

27

 

 

 

53

 

 

 

23

 

 

 

15

 

 

 

38

 

 

 

9

 

 

 

359

 

 

 

459

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Depreciation and amortization

 

15

 

 

 

20

 

 

 

35

 

 

 

21

 

 

 

4

 

 

 

25

 

 

 

4

 

 

 

-

 

 

 

64

 

     Operating key items

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

     Net income (loss) on divestitures key items

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

     Income (loss) from discontinued operations

     (net of taxes)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(384

)

 

 

(384

)

     Gain on pension and other postretirement

     plan remeasurements

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

11

 

 

 

11

 

Adjusted EBITDA (non-GAAP)

$

41

 

 

$

47

 

 

$

88

 

 

$

44

 

 

$

19

 

 

$

63

 

 

$

13

 

 

$

(14

)

 

$

150

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 5 - Continued

 

RECONCILIATION OF CERTAIN NON-GAAP DATA

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS from continuing operations (as reported)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.44

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Restructuring, separation and other costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     Gain on pension and other postretirement

     plan measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.18

 

     Unrealized (gain) loss on securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.07

)

     Debt Refinancing Costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.09

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.20

 

Tax effect of key items (a)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.05

)

Key items, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.15

 

Tax specific key items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Uncertain tax positions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.03

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.21

 

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.06

)

Tax specific key items (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.18

 

Total key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.33

 

Adjusted diluted EPS from continuing operations (non-GAAP)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.77

 

Amortization expense, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.26

 

Adjusted diluted EPS from continuing operations excluding

intangible amortization expense (non-GAAP)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

1.03

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Diluted Common Shares Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Represents the tax effect of the key items that are previously identified above.

 

(b) Represents key items resulting from tax specific financial transactions, tax law changes or other matters that fall within the definition of tax specific key items.

 

 

 

 

19

 


 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 6

 

STATEMENTS OF CONSOLIDATED INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

Sales

$

155

 

 

$

137

 

 

$

292

 

 

$

139

 

 

$

74

 

 

$

213

 

 

$

28

 

 

$

-

 

 

$

533

 

Cost of sales

 

 

 

 

 

 

 

 

 

189

 

 

 

 

 

 

 

 

 

 

 

154

 

 

 

37

 

 

 

-

 

 

 

380

 

GROSS PROFIT

 

 

 

 

 

 

 

 

 

103

 

 

 

 

 

 

 

 

 

 

 

59

 

 

 

(9

)

 

 

-

 

 

 

153

 

Selling, general and administrative expense

 

 

 

 

 

 

 

 

 

44

 

 

 

 

 

 

 

 

 

 

 

29

 

 

 

2

 

 

 

24

 

 

 

99

 

Research and development expense

 

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

-

 

 

 

-

 

 

 

16

 

Intangible amortization expense

 

 

 

 

 

 

 

 

 

16

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

-

 

 

 

-

 

 

 

21

 

Equity and Other Income

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

OPERATING INCOME (LOSS)

 

22

 

 

 

11

 

 

 

33

 

 

 

8

 

 

 

11

 

 

 

19

 

 

 

(11

)

 

 

(24

)

 

 

17

 

Net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10

 

 

 

10

 

Other net periodic benefit income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

Net income (loss) on divestitures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

3

 

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

22

 

 

 

11

 

 

 

33

 

 

 

8

 

 

 

11

 

 

 

19

 

 

 

(11

)

 

 

(31

)

 

 

10

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(24

)

 

 

(24

)

INCOME (LOSS) FROM CONTINUING OPERATIONS

 

22

 

 

 

11

 

 

 

33

 

 

 

8

 

 

 

11

 

 

 

19

 

 

 

(11

)

 

 

(7

)

 

 

34

 

Income (loss) from discontinued operations (net of income taxes)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2

)

 

 

(2

)

NET INCOME (LOSS)

$

22

 

 

$

11

 

 

$

33

 

 

$

8

 

 

$

11

 

 

$

19

 

 

$

(11

)

 

$

(9

)

 

$

32

 

 

 

 

20

 


 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 6 - Continued

 

SEGMENT COMPONENTS OF KEY ITEMS FOR APPLICABLE INCOME STATEMENT CAPTIONS

 

 

 

 

 

 

 

 

 

 

 

 

 

(In millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OPERATING INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating key items

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

(7

)

 

$

(7

)

All other operating income (loss)

 

22

 

 

 

11

 

 

 

33

 

 

 

8

 

 

 

11

 

 

 

19

 

 

 

(11

)

 

 

(17

)

 

 

24

 

Operating income (loss)

 

22

 

 

 

11

 

 

 

33

 

 

 

8

 

 

 

11

 

 

 

19

 

 

 

(11

)

 

 

(24

)

 

 

17

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INTEREST AND OTHER EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9

)

 

 

(9

)

All other net interest and other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19

 

 

 

19

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET INCOME (LOSS) ON DIVESTITURES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

All other net income (loss) on divestitures key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME TAX EXPENSE (BENEFIT)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1

 

 

 

1

 

Tax specific key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25

)

 

 

(25

)

All other income tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

OTHER NET PERIODIC BENEFIT INCOME (COSTS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INCOME (LOSS) FROM CONTINUING OPERATIONS

$

22

 

 

$

11

 

 

$

33

 

 

$

8

 

 

$

11

 

 

$

19

 

 

$

(11

)

 

$

(7

)

 

$

34

 

 

21

 


Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 6 - Continued

 

RECONCILATION OF NON-GAAP DATA - ADJUSTED EBITDA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) (as reported)

$

22

 

 

$

11

 

 

$

33

 

 

$

8

 

 

$

11

 

 

$

19

 

 

$

(11

)

 

$

(9

)

 

$

32

 

Income tax expense (benefit)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

(24

)

 

 

(24

)

Net interest and other expense

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

10

 

 

 

10

 

Subtotal

 

22

 

 

 

11

 

 

 

33

 

 

 

8

 

 

 

11

 

 

 

19

 

 

 

(11

)

 

 

(23

)

 

 

18

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Depreciation and amortization

 

15

 

 

 

19

 

 

 

34

 

 

 

21

 

 

 

4

 

 

 

25

 

 

 

2

 

 

 

-

 

 

 

61

 

     Operating key items

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7

 

 

 

7

 

     Net income (loss) on divestitures key items

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

     Income (loss) from discontinued operations

     (net of taxes)

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

2

 

 

 

2

 

     Gain on pension and other postretirement

     plan remeasurements

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

-

 

 

 

 

 

 

 

-

 

 

 

-

 

Adjusted EBITDA (non-GAAP)

$

37

 

 

$

30

 

 

$

67

 

 

$

29

 

 

$

15

 

 

$

44

 

 

$

(9

)

 

$

(14

)

 

$

88

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ashland Global Holdings Inc. and Consolidated Subsidiaries

 

 

 

 

 

 

Table 6 - Continued

 

RECONCILATION OF CERTAIN NON-GAAP DATA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data - preliminary and unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended December 31, 2019

 

 

Life Sciences

 

 

Personal Care

& Household

 

 

Consumer Specialties

 

 

Specialty Additives

 

 

Performance Adhesives

 

 

Industrial Specialties

 

 

Intermediates & Solvents

 

 

Corporate & Other

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted EPS from continuing operations (as reported)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.56

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Restructuring, separation and other costs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.12

 

     Gain on pension and other postretirement

     plan measurements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     Unrealized (gain) loss on securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.15

)

     Net loss on acquisitions and divestitures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

Key items, before tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.03

)

Tax effect of key items (a)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.02

 

Key items, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.01

)

Tax specific key items (b):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

     Deferred tax rate changes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     One-time transition tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     Restructuring and separation activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-

 

     Other tax reform related activity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.42

)

Tax specific key items:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.42

)

Total key items

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.43

)

Adjusted diluted EPS from continuing operations (non-GAAP)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.13

 

Amortization expense, after tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0.28

 

Adjusted diluted EPS from continuing operations

excluding intangible amortization expense (non-GAAP)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.41

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average Diluted Common Shares Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Represents the tax effect of the key items that are previously identified above.

 

(b) Represents key items resulting from tax specific financial transactions, tax law changes or other matters that fall within the definition of tax specific key items.

 

 

 

 

23

 


 

Use of Non-GAAP Measures

 

Ashland has included within this document the following non-GAAP measures, on both a consolidated and reportable segment basis, which are not defined within U.S. GAAP and do not purport to be alternatives to net income or cash flows from operating activities as a measure of operating performance or cash flows:

 

 

EBITDA – net income (loss), plus income tax expense (benefit), net interest and other expenses, and depreciation and amortization.

 

 

 

Adjusted EBITDA – EBITDA adjusted for noncontrolling interests, discontinued operations, net income (loss) on acquisitions and divestitures, other income and (expense) and key items (including the remeasurement gains and losses related to pension and other postretirement plans).

 

 

 

Adjusted EBITDA margin – Adjusted EBITDA divided by sales.

 

 

 

Adjusted diluted earnings per share (EPS) – income (loss) from continuing operations, adjusted for key items, net of tax, divided by the average outstanding diluted shares for the applicable period.

 

 

 

Adjusted diluted earnings per share (EPS) excluding intangibles amortization expense – Adjusted earnings per share adjusted for intangibles amortization expense net of tax, divided by the average outstanding diluted shares for the applicable period.

 

 

Management believes the use of EBITDA and Adjusted EBITDA measures on a consolidated and reportable segment basis assists investors in understanding the ongoing operating performance by presenting comparable financial results between periods. Ashland believes that by removing the impact of depreciation and amortization and excluding certain non-cash charges, amounts spent on interest and taxes and certain other charges that are highly variable from year to year, EBITDA and Adjusted EBITDA provide Ashland’s investors with performance measures that reflect the impact to operations from trends in changes in sales, margin and operating expenses, providing a perspective not immediately apparent from net income and operating income. The adjustments Ashland makes to derive the non-GAAP measures of EBITDA and Adjusted EBITDA exclude items which may cause short-term fluctuations in net income and operating income and which Ashland does not consider to be the fundamental attributes or primary drivers of its business. EBITDA and Adjusted EBITDA provide disclosure on the same basis as that used by Ashland’s management to evaluate financial performance on a consolidated and reportable segment basis and provide consistency in our financial reporting, facilitate internal and external comparisons of Ashland’s historical operating performance and its business units and provide continuity to investors for comparability purposes.

 

The Adjusted diluted EPS metric enables Ashland to demonstrate what effect key items have on an earnings per diluted share basis by taking income (loss) from continuing operations, adjusted for key items after tax that have been identified in the Adjusted EBITDA table, and dividing by the average outstanding diluted shares for the applicable period. Ashland’s management believes this presentation is helpful to illustrate how the key items have impacted this metric during the applicable period.

 

The Adjusted diluted EPS, excluding intangibles amortization expense metric enables Ashland to demonstrate the impact of non-cash intangibles amortization expense on EPS. Ashland’s management believes this presentation is helpful to illustrate how previous acquisitions have impacted applicable period results.

 

These non-GAAP measures should be considered supplemental in nature and should not be construed as more significant than comparable measures defined by U.S. GAAP. Limitations associated with the use of these non-GAAP measures include that these measures do not present all of the amounts associated with our results as determined in accordance with U.S. GAAP. The non-GAAP measures provided are used by Ashland’s management and may not be determined in a manner consistent with the methodologies used by other companies. EBITDA and Adjusted EBITDA provide a supplemental presentation of Ashland’s operating performance on a consolidated and reportable segment basis.

 

 

24

 


 

™ Trademark, Ashland or its subsidiaries, registered in various countries.

 

The information in this Current Report on Form 8-K is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

25


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ASHLAND GLOBAL HOLDINGS INC.

 

(Registrant)

 

 

April 28, 2020

/s/ J. Kevin Willis

 

J. Kevin Willis

 

Senior Vice President and Chief Financial Officer

 

26

EX-101.SCH 2 ash-20200428.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document And Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 ash-20200428_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Entity File Number Entity File Number Entity Incorporation State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address Address Line1 Entity Address Address Line1 Entity Address City or Town Entity Address City Or Town Entity Address State or Province Entity Address State Or Province Entity Address Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre Commencement Tender Offer Pre-commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Title of each class Security12b Title Trading Symbol Trading Symbol Name of each exchange on which registered Security Exchange Name EX-101.PRE 4 ash-20200428_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports ash-8k_20200428.htm ash-20200428.xsd ash-20200428_lab.xml ash-20200428_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 ash-8k_20200428_htm.xml IDEA: XBRL DOCUMENT 0001674862 2020-04-28 2020-04-28 false 0001674862 8-K 2020-04-28 ASHLAND GLOBAL HOLDINGS INC. DE 333-211719 81-2587835 8145 Blazer Drive Wilmington DE 19808 302 995-3000 false false false false false Common Stock (par value $.01) ASH NYSE XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 10 0001564590-20-018982-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-20-018982-xbrl.zip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htm IDEA: XBRL DOCUMENT v3.20.1
Document And Entity Information
Apr. 28, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 28, 2020
Entity Registrant Name ASHLAND GLOBAL HOLDINGS INC.
Entity Central Index Key 0001674862
Entity Emerging Growth Company false
Entity File Number 333-211719
Entity Incorporation State or Country Code DE
Entity Tax Identification Number 81-2587835
Entity Address Address Line1 8145 Blazer Drive
Entity Address City or Town Wilmington
Entity Address State or Province DE
Entity Address Postal Zip Code 19808
City Area Code 302
Local Phone Number 995-3000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of each class Common Stock (par value $.01)
Trading Symbol ASH
Name of each exchange on which registered NYSE
JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ash-8k_20200428.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "ash-8k_20200428.htm" ] }, "labelLink": { "local": [ "ash-20200428_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "ash-20200428_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "ash-20200428.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ash", "nsuri": "http://investor.ashland.com/20200428", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "ash-8k_20200428.htm", "contextRef": "C_0001674862_20200428_20200428", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document And Entity Information", "role": "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "ash-8k_20200428.htm", "contextRef": "C_0001674862_20200428_20200428", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "verboseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address Address Line1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of each class" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Name of each exchange on which registered" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://investor.ashland.com/20200428/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }